XCath Robotics Receives FDA Breakthrough Device Designation for the Iris System for Remote Robotic-Assisted Mechanical Thrombectomy in Acute Ischemic Stroke
XCath Robotics, a medical device company advancing endovascular surgical robotics, announced today the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its Iris Surgical Robotic System for remote robotic-assisted mechanical thrombectomy in patients with acute ischemic stroke.
